Ajax-Loading

Hansoh Pharmaceutical Group Co Ltd - End Period Cash Flow

Hansoh Pharmaceutical Group Co Ltd's Fiscal Year is From January To December - All Figures are in HKD, Billions.

The item "End-Period-Cash-Flow" stands at 2.32 Billion Hong Kong Dollars for the trailing twelve months (TTM) period ending 06/30/2025, the lowest value since 03/31/2019.'
Regarding the One-Year-Change of the series, the current value constitutes a decrease of -81.12 percent compared to the value the year prior.
The 1 year change in percent is -81.12.
The 3 year change in percent is -90.63.
The 5 year change in percent is -80.87.

The Serie's long term average value is 9.68 Billion Hong Kong Dollars. It's latest available value, on 06/30/2025, is 76.00 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 12/31/2016, to it's latest available value, on 06/30/2025, is +1,259.40%.
The Serie's change in percent from it's maximum value, on 03/31/2022, to it's latest available value, on 06/30/2025, is -92.44%.

End Period Cash Flow for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - End Period Cash Flow905,699,262,464.00
LogoJohnson & Johnson - End Period Cash Flow486,508,953,600.00
LogoAbbVie Inc - End Period Cash Flow399,570,305,024.00
LogoRoche Holding AG - End Period Cash Flow317,433,206,677.55
LogoAstraZeneca PLC - End Period Cash Flow280,205,508,085.11